Monitra Health has raised new funding to accelerate the growth of its flagship cardiac monitoring platform, UpBeat, strengthening its position in the rapidly evolving global digital health market.
UpBeat is designed as a Continuous Remote Cardiac Monitoring Solution, enabling real time tracking of heart activity and early detection of abnormalities. By combining wearable technology with AI-driven analytics, the platform helps clinicians monitor patients remotely and intervene proactively when risks are detected.
The newly secured funding will support Product Development, Global Expansion, And Scaling Of Operations, as Monitra Health looks to increase adoption of its technology across international markets. The company aims to enhance its AI capabilities and integrate more advanced features to improve predictive accuracy and patient outcomes.
Cardiovascular diseases remain one of the leading causes of death worldwide, driving demand for innovative solutions that enable Early Detection And Continuous Monitoring. Platforms like UpBeat are addressing this need by shifting care from hospitals to homes, improving accessibility and reducing the burden on healthcare systems.
Industry experts view Monitra Health’s growth as part of a broader trend toward Remote Patient Monitoring And Digital Therapeutics, where technology plays a critical role in managing chronic conditions and improving long term health outcomes.
With increasing adoption of connected health devices and AI-powered analytics, Monitra Health is positioning itself as a key player in the future of Personalized, Data Driven Cardiac care on a global scale.
“Continuous monitoring and early detection are transforming how we manage cardiac health worldwide.”
By
HB Team
